European efforts seek to address the challenges of an aging population and also create opportunities for economic growth and innovation.
It was the inaugural day of the study in 2005 when Brad Manor went out into the hot Louisiana sun to meet his first patient, James. Manor, now director of the Mobility and Brain Function Lab at the Harvard-affiliated Institute for Aging Research, was, at that time, a Ph.D. student at Louisiana State University.
Approximately 360 million people in the world live with a debilitating hearing loss.
Even as recently as the mid-1980s, many experts in otology and auditory science thought that restoration of useful hearing with crude and pervasive electrical stimulation of the cochlea was a fool’s dream.
Pinpointing where healthy brain aging leaves off and dementia begins is difficult. Is a slip in memory an expected outcome for a too-busy person or a warning of something else?
As much as we know about the vitamins, minerals, and types of exercise important to promoting good muscle health, many fundamental questions remain about skeletal and cardiac muscle.
Advances in automated data processing and machine learning now allow epidemiologists to meticulously sift through the millions of digital traces we collectively leave behind each day as we conduct our lives online—through Internet searches, social media posts, or the use of our mobile phones.
Cell phone chimes, sticky notes, even the proverbial string around a finger—these timehonored external cues help guard against our inevitable memory lapses. But some internal help to the brain itself may be on the way in the form of what’s being called memory prosthetics.
Elite-level athletes and professional sports teams are continually searching for opportunities to improve athletic performance and gain a competitive advantage on the field. Advances in technology have provided new avenues to maximize player health and safety.
Taken as a whole, rare diseases are not very rare. Even though a rare disease by definition is one that affects fewer than 200,000 Americans or fewer than one in 2,000 Europeans at any time, when rare diseases are considered together, they affect some 350 million people worldwide.